2
icotec AG Received FDA Clearance to Market BlackArmor® Carbon/PEEK Interbody Cages
mehr
Stockholm (ots/PRNewswire) - OxThera AB, a Stockholm-based privately-held biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria (PH), announces the appointment of Dr Alain Munoz to its board of directors. "It is my pleasure to welcome Alain to the board of Oxthera," said Dr. Georges Gemayel, Chairman of Oxthera. ...
Montréal (ots/PRNewswire) - - One-year total portfolio net return of 9.8% generated $13.5 billion of net income, net of all PSP costs. - Five-year annualized net return of 10.5% which is 1.1% above the Policy Portfolio benchmark return. - Ten-year net annualized return of 7.1% generated $23.8 billion of cumulative ...